Friday, November 22, 2024
Advertisement
Updated on: April 30, 2024 16:20 IST

AstraZeneca admits Covishield vaccine could cause 'rare' blood clots in body, sparks concern

AstraZeneca has acknowledged a potential rare side effect associated with its COVID-19 vaccine, including Covishield, the version widely used in India. This admission, made in legal documents submitted to the UK High Court, has sparked public concern and raised questions about vaccine safety.
Advertisement
Advertisement
Advertisement
Advertisement